Lantern Pharma logo

Lantern Pharma

LTRN | NASDAQ
Chart Builder DCF Calculator
$0.46
-$0.14 (-23.21%)
At close: Nov 10, 2026, 4:00 PM ET
-23.21%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 10, 2026
22.8
+1.6 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #969/1027 (Top 94%)

Key Statistics

Market Data

Market Cap $6.92M
1D Range
0.45 0.67
52W Range
0.45 4.17

Valuation (TTM)

PE -0.28
PB -2.15
EV/EBITDA 0.02

Valuation (NTM)

Forward PE N/A
Forward PEG 0.15
Price Target $0.00
Loading financial charts...

Profile

Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensi...

Sector Healthcare
Industry Biotechnology
Employees 16
IPO Date Jun 11, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.